In-home COVID-19 Testing For Children With Medical Complexity
Caregivers of children with medical complexity are increasingly using Direct Antigen Rapid Testing (DART) to determine if their children have COVID-19.
TreeBREAD Review
Research article overview in layman's terms.
Caregivers of children with medical complexity are increasingly using Direct Antigen Rapid Testing (DART) to determine if their children have COVID-19. This qualitative study investigated their perceptions of the benefits and limitations of this in-home testing. Caregivers found that testing with DART helped them feel more at ease and could give them important information to help their child’s school know whether they were safe to attend.
However, there were also some demotivators, such as the thought that their child could still get COVID-19 even after testing. Future research should look into how to make DART easier for high-risk populations, while still providing important information that can reduce caregiver burden.
Caregiver perceptions of in-home COVID-19 testing for children with medical complexity: a qualitative study
Abstract
Direct Antigen Rapid Testing (DART)
In-home direct antigen rapid testing (DART) plays a major role in COVID-19 mitigation and policy. However, perceptions of DART within high-risk, intellectually impaired child populations are unknown. This lack of research could negatively influence DART uptake and utility among those who stand to benefit most from DART. The purpose of this study was to describe caregivers perceptions of an in-home COVID-19 DART regimen in children with medical complexity, including the benefits and limitations of DART use.
Methods
This qualitative study was a subproject of the NIH Rapid Acceleration of Diagnostics Underserved Populations research program at the University of Wisconsin. We combined survey data and the thematic analysis of semi-structured interview data to understand caregivers perceptions of in-home COVID-19 testing and motivators to perform testing. Caregivers of children with medical complexity were recruited from the Pediatric Complex Care Program at the University of Wisconsin (PCCP). Data were collected between May and August 2021.
Results
Among n =20 caregivers, 16/20 (80%) of their children had neurologic conditions and 12/20 (60%) used home oxygen. Survey data revealed that the largest caregiver motivators to test their child were to get early treatment if positive (18/20 [90%] of respondents agreed) and to let the childs school know if the child was safe to attend (17/20 [85%] agreed). Demotivators to testing included that the child could still get COVID-19 later (7/20 [35%] agreed), and the need for officials to reach out to close contacts (6/20 [30%] agreed). From interview data, four overarching themes described perceptions of in-home COVID-19 testing: Caregivers perceived DART on a spectrum of 1) benign to traumatic and 2) simple to complex. Caregivers varied in the 3) extent to which DART contributed to their peace of mind and 4) implications of test results for their child.
Conclusions
Although participants often described DART as easy to administer and contributing to peace of mind, they also faced critical challenges and limitations using DART. Future research should investigate how to minimize the complexity of DART within high-risk populations, while leveraging DART to facilitate safe school attendance for children with medical complexity and reduce caregiver burden.
Authors
Journal
Published Date
DOI:
What's Your View on this Research Article?

Sharing is Loving
Is this website helping you in any way? We love to hear your feedback. Write to us and spread the words : )
0 Comments